TechNavio's analysts forecast the Global Personalized Medicine market 2012-2016 to grow at a CAGR of 12.07 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant growth of the Targeted Biologics segment. The Global Personalized Medicine market has also been witnessing an increase in the number of mergers ad acquisitions. However, the low awareness of personalized medicine in developing countries could pose a challenge to the growth of this market. To View the Detail Report Visit : http://www.researchmoz.us/future-prospects-of-global-personalized-medicine-market-2012-2016-report.html TechNavio's report, the Future Prospects of Global Personalized Medicine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Personalized Medicine market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

1. Future Prospects of Global Personalized Medicine Market 2012-2016
TechNavio's analysts forecast the Global Personalized Medicine market 2012-2016 to grow at a CAGR of
12.07 percent over the period 2012-2016. One of the key factors contributing to this market growth is the
significant growth of the Targeted Biologics segment. The Global Personalized Medicine market has also been
witnessing an increase in the number of mergers ad acquisitions. However, the low awareness of personalized
medicine in developing countries could pose a challenge to the growth of this market.
TechNavio's report, the Future Prospects of Global Personalized Medicine Market 2012-2016, has been
prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market
in the Americas, and the EMEA and APAC regions; it also covers the Global Personalized Medicine market
landscape and its growth prospects in the coming years. The report also includes a discussion of the key
vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, AstraZeneca plc, F. Hoffmann-La Roche
Ltd., Novartis AG, Pfizer Inc., and Sanofi S.A.
The other vendors mentioned in the report are Affymetrix Inc., Agendia B.V., Agilent Technologies Inc.,
Amgen Inc., Astellas Pharma Inc., Baxter International Inc., Bayer AG, BG Medicine Inc., Biocartis S.A,
Biogen Idec Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co., Celgene Corp., Daiichi Sankyo
Co. Ltd., Danaher Corp., Eli Lilly and Co., Evotec AG, GE Healthcare Ltd., Genelex Corp., GlaxoSmithKline
plc, Hologic Inc., Johnson & Johnson, Laboratory Corporation of America Holdings, Life Technologies Corp.,
Merck KGaA, Mitsubishi Tanabe Pharma Corp., Myriad Genetics Inc., Novartis AG, PerkinElmer Inc., Pfizer
Inc., Quest Diagnostics Inc., Sanofi S.A., Siemens Healthcare, Sigma-Aldrich Corp., Takeda Pharmaceutical
Co. Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Transgenomic Inc.
Key questions answered in this report:
What will the market size be in 2016 and what will be the growth rate? What are key market trends? What is
driving this market? What are the challenges to market growth? Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of
each of these key vendors?
table Of Content
1. Executive Summary
2. List Of Abbreviations
3. Introduction
Future Prospects of Global Personalized Medicine Market 2012-2016

2. 4. Market Research Methodology
market Research Process
research Design
research Methodology
5. Scope Of The Report
market Overview
product Offerings
6. Market Landscape
6.1 Market Size And Forecast
6.2 Key Market Segmentation
segmentation By Product Types
global Targeted Biologics Market
global Proteomics And Genomics Market
segmentation By Application Technologies
6.3 Five Forces Analysis
7. Geographical Segmentation
8. Key Leading Countries
usa
germany
japan
9. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers And Their Impact
13. Market Challenges
Future Prospects of Global Personalized Medicine Market 2012-2016

3. 14. Impact Of Drivers And Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 Abbott Laboratories
business Overview
key Information
swot Analysis
16.2 Astrazeneca Plc
business Overview
key Information
swot Analysis
16.3 F. Hoffmann-la Roche Ltd.
business Overview
key Information
swot Analysis
16.4 Novartis Ag
business Overview
key Information
swot Analysis
16.5 Pfizer Inc.
business Overview
key Information
swot Analysis
16.6 Sanofi S.a.
business Overview
key Information
swot Analysis
17. Other Reports In This Series
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Future Prospects of Global Personalized Medicine Market 2012-2016

4. Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Future Prospects of Global Personalized Medicine Market 2012-2016